Companion Diagnostics Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2027 – EIN News

There were 635 press releases posted in the last 24 hours and 186,929 in the last 365 days.
Emergen Research Logo
Rising the incidence of cancer worldwide, the demand for customized medication and tailored treatment coupled with the recognition by industry participants
VANCOUVER, BC, CANADA, November 11, 2021 / — A recent market intelligence study on the Companion Diagnostics market incorporates proprietary techniques and assessment tools to screen the Companion Diagnostics market for the forecast period, 2020-2027. Additionally, valuable insights pertaining to the market size, share and growth rate of Companion Diagnostics market offers a greater chance of success for all – business owners, products, and innovative technology. Unbiased perspective on present day and yesteryear trends included in the research aims at saving the product owners from making wrong business decisions
Increasing emphasis on personalized medicine should pave the way for companion diagnostics because it forms an integral part of personalized medicine. Owing to increased identification, care, and surveillance of a variety of illnesses, biomarkers and companion diagnostics have seen strong demand. Such diagnostic assessments increase the product development cycle by rising and growing the research and development costs and raising the approval rates of the drug.
Get Pdf Sample of the Report@
The strategic growth research technique adopted by the subject matter experts behind this study full weighs upon the product application, product types and important industry terminologies and definition to help business owners to build a robust business plan as well as a progressive map for their product and services. Moreover, the agile methods to assess various factors including demand and supply status, consumption volume, customer preference, spending capacity and import and export trends work as a boon to those diversifying in a new line of product. To triangulate the different aspects of data on the Companion Diagnostics market critical data are showcased intellectually through resources such as infographics, charts, and tables.
Companies profiled in the global Companion Diagnostics market:
Agilent Technologies, Foundation Medicine, Myriad Genetic Laboratories, Thermo Fisher Scientific, Johnson & Johnson, Arup Laboratories, Abbott, MolecularMD, BioMérieux, and Illumina, among others.

 Key Highlights
Based on technology, genetic sequencing generated a revenue of USD 0.47 billion in 2019. It projected to rise with a CAGR of 17.6% in the forecast period due to the highly technological sequencing methods that allow the detection of mutations, fusions, alterations in copy numbers, tumor mutation burden, microsatellite instability, etc.
The skin cancer disease indication expected to grow with a CAGR of 18.1% in the forecasted period attributable to the increasing skin cancer incidence due to medication side effects and prolonged sensitivity to toxic sun rays are helping doctors to manage patients with skin cancer.
The hospital application is the major contributor to the Companion Diagnostics Market. The hospital application of the North America region is the major shareholder of the market and held around 59.5% of the market in the year 2019, due to the availability of established hospital infrastructure, and qualified professionals increase the inclination of patients towards hospitals coupled with the growing patient pool due to a high incidence of chronic diseases would be helpful for the growth of the market.
 Regional Overview:
The global Companion Diagnostics market has been categorized on the basis of key geographical regions into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. It evaluates the presence of the global Companion Diagnostics market in the major regions with regards to market share, market size, revenue contribution, sales network and distribution channel, and other key elements.
To Get discount@
For the purpose of this report, Emergen Research has segmented into the global Companion Diagnostics Market based on the technology, disease indication, application, and region:
Technology Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
In Situ Hybridization
Polymerase Chain Reaction
Genetic Sequencing
Disease Indication Outlook (Volume, Kilotons; 2017-2027, Revenue, USD Billion; 2017-2027)
Breast Cancer
Lung Cancer
Colorectal Cancer
Skin Cancer
Application Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
Diagnostic Laboratories
 Key point summary of the report:
The report offers a comprehensive overview of the market size, share, and growth rate in the forecast duration.
It provides details about current scenario, historical data, giving an accurate market forecast for the coming years.
The study categorizes the market on the basis of product types, applications, end users, market value and volume, business verticals, and 5 major regions.
It also offers regional market analysis and forecast for prominent geographies in the sector viz., North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Industry supply chain, sourcing strategy, upstream feedstock, and downstream demand analysis has also been undertaken in the research report.
The study offers a comprehensive understanding of the demand and supply dynamics, including production and consumption rates, and mapping of the overall market.
The report employs different analytical tools including, SWOT analysis, Porter’s five forces analysis, and pricing analysis, to give precise market information.
Directly Purchase/Place an Order @
Table of Content
Chapter 1. Market Synopsis
    1.1. Market Definition
    1.2. Research Scope & Premise
    1.3. Methodology
    1.4. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Companion Diagnostics Market Segmentation & Impact Analysis
    4.1. Companion Diagnostics Market Product Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
           Increasing drug diagnostic co-development
           Improving regulatory scenario
           Growing incidences of adverse drug reaction
          4.2.3. Market restraints analysis
           High cost of companion diagnostics test in developing and underdeveloped regions
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. ETOP Analysis
    4.6. Porter’s Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price trend Analysis
    4.9. Customer Mapping
    4.10. Covid-19 Impact Analysis
    4.11. Global Recession Influence
Chapter 5. Companion Diagnostics Market By Technology Insights & Trends
    5.1. Technology Dynamics & Market Share, 2020 & 2027
    5.2. Immunohistochemistry
          5.2.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)
          5.2.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
    5.3. In Situ Hybridization
          5.3.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)
          5.3.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
    5.4. Polymerase Chain Reaction
          5.4.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)
          5.4.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
    5.5. Genetic Sequencing
          5.5.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)
          5.5.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
To click for customization Report @:
 Thank you for reading our report. The report can be customized as per requirement. Please get in touch with us for further inquiry and we will ensure you get the report best suited for your needs.
Explore Similar Reports offered by Emergen Research:
Phototherapy Devices Market@
NGS Sample Preparation Market@
Next Generation Sequencing Market@
DNA Origami Market @
Smart Contact Lens Market@
 About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Eric Lee
Emergen Research
+91 90210 91709
[email protected]
Visit us on social media:
You just read:

EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™, tries to define some of the boundaries that are reasonable in today’s world. Please see our Editorial Guidelines for more information.

Follow EIN Presswire
© 1995-2021 IPD Group, Inc. dba EIN Presswire All Right Reserved.